Karine Smans Selected Research

soraphen A

1/2014	Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment.
10/2010	De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karine Smans Research Topics

Disease

7	Neoplasms (Cancer) 01/2018 - 10/2010
1	Diarrhea 01/2018
1	Carcinogenesis 07/2014
1	Liposarcoma 10/2013
1	Starvation 09/2012

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 07/2014 - 10/2010
2	soraphen AIBA 01/2014 - 10/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 10/2010
2	CholesterolIBA 01/2014 - 09/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2013 - 09/2012
2	EnzymesIBA 10/2013 - 10/2010
2	Small Interfering RNA (siRNA)IBA 09/2012 - 10/2010
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2018
1	AnionsIBA 01/2018
1	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2018
1	PalmitatesIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 07/2014
1	Nonesterified Fatty Acids (NEFA)IBA 01/2014
1	Simvastatin (Zocor)FDA LinkGeneric 01/2014
1	VLDL LipoproteinsIBA 01/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2013
1	Dietary Fats (Dietary Fat)IBA 10/2013
1	Sterol Regulatory Element Binding ProteinsIBA 09/2012
1	Acetates (Acetic Acid Esters)FDA Link 09/2012
1	ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA 08/2012
1	Membrane LipidsIBA 10/2010
1	Free RadicalsIBA 10/2010
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2010

Therapy/Procedure

2	Therapeutics 01/2018 - 09/2012